| 查看: 1333 | 回复: 12 | ||
| 【奖励】 本帖被评价9次，作者海天天意增加金币 7.2 个 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[资源]
Chem. Rev.11.25新鲜上线：Nanomaterials for Theranostics: Recent Advances
|
||
|
Nanomaterials for Theranostics: Recent Advances and Future Challenges Eun-Kyung Lim,†,‡,§ Taekhoon Kim,∥,⊥,§ Soonmyung Paik,#,∇ Seungjoo Haam,○ Yong-Min Huh,*,† and Kwangyeol Lee*,∥ （68页，907篇文献） CONTENTS 1. Introduction A 1.1. What Are the Key Biological Processes Pertinent to Diseases, and How Can These Processes Be Monitored? C 1.2. What Is the Core Advantage of in Vivo Imaging over in Vitro Assays? C 1.3. What Are the Key Challenges That Need To Be Addressed To Overcome the Fundamental Limitations of in Vivo Imaging? C 2. Major Cancer Signaling Pathways and the Concept of Targeted Delivery D 3. Design of Theranostic Nanoparticles F 3.1. Biomedical Payloads F 3.1.1. Imaging F 3.1.2. Therapeutics I 3.2. Carrier M 3.2.1. Polymers N 3.2.2. Lipids N 3.2.3. Dendrimers N 3.2.4. Inorganic Nanocarriers O 3.3. Surface Modifiers O 4. Pharmacokinetic and Pharmacodynamic Properties of Nanomaterial-Based Therapy P 5. Theranostic Nanomaterials R 5.1. Magnetic Nanoparticles R 5.1.1. Magnetic Nanoparticles as Imaging Agents T 5.1.2. Magnetic Nanoparticles as Drug Delivery Vehicles AD 5.1.3. Magnetic Nanoparticles as Hyperthermal Agents AE 5.1.4. Magnetic Nanoparticles as Anticancer Drugs AG 5.2. Quantum Dots (QDs) AH 5.2.1. Strategies for Reduced RES Uptake AI 5.2.2. Anticancer Drug and Other Chemical Drug Delivery AI 5.2.3. Gene Delivery AJ 5.3. Metal Nanoparticles AJ 5.3.1. Metal Nanoparticle as Imaging Agent AK 5.3.2. Metal Nanoparticle as Photothermal Agent AM 5.3.3. Drug Release Triggered by Metal Nanoparticle-Based Hyperthermia AO 5.4. Upconversion Nanoparticles (UCNPs) AS 5.4.1. Imaging Agent AS 5.4.2. Photosensitizer Activator AS 5.5. Silica and Other Inorganic Nanomaterials AT 5.5.1. Silica AT 5.5.2. Calcium Phosphate AV 5.5.3. Apatite AV 5.5.4. Metal Organic Frameworks (MOFs) AV 5.6. Carbon-Based Nanomaterials AW 5.6.1. Carbon Nanomaterials as Carrier AW 5.6.2. Carbon Materials for Photothermal Therapy AY 6. Summary and Outlook AZ Author Information BA Corresponding Authors BA Author Contributions BA Notes BA Biographies BA Acknowledgments BB Abbreviations BB References BC  normal.img-002 (1).jpg |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : Nanomaterials_for_Theranostics-cr300213b.pdf
2014-11-26 14:25:13, 3.69 M
» 猜你喜欢
请问投稿的时候application packages是什么？
已经有0人回复
-
爱思唯尔投稿的脚注(Footnotes)放在页面下部还是文章最后？
已经有2人回复
-
法医学论文润色/翻译怎么收费?
已经有118人回复
-
双盲审稿的修改说明中如何署名呢？
已经有6人回复
-
这句审稿意见是什么意思呢？ What can the real industrial practices.........
已经有4人回复
-
修改后又多了两个审稿人吗？有图。
已经有6人回复
-
论文接收后请求增加一个作者单位，这算是同意了吗
已经有2人回复
-
324求调剂
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
4楼2014-11-26 18:14:16
3楼2014-11-26 18:10:42
6楼2014-12-08 20:36:00
12楼2016-10-18 14:55:34
简单回复
2015-08-03 10:11
回复
五星好评 顶一下，感谢分享！
XJP100710楼
2015-10-14 20:15
回复
五星好评 顶一下，感谢分享！
sunshaokai13楼
2017-01-19 20:13
回复
五星好评 顶一下，感谢分享！
w82171742楼
2014-11-26 14:54
回复
五星好评 顶一下，感谢分享！
sola仰望天空7楼
2015-01-26 21:32
回复
五星好评 顶一下，感谢分享！
Jackcd1211楼
2016-10-18 00:01
回复
五星好评 顶一下，感谢分享！
quan12zf5楼
2014-11-26 23:19
回复
五星好评 顶一下，感谢分享！
zhuangq8楼
2015-07-17 16:56
回复
五星好评 顶一下，感谢分享！
